Please assess the completion status of the following clinical trial:

Trial Title: Implementation of a Protocol Utilizing Adaptive CRT in a Normal AV Conduction, CRT Non-Response Population at Generator Replacement

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Normal AV conduction (SAV\<220 ms or PAV\<270 MS)~* Left Bundle Branch Block (defined as \> or = to 140 ms (male) or \> or = 130 (female), QR or rS in leads V1 and V2, and Mid QRS notching or slurring in v 2 of leads V1, V2, V5, V6 and I and aVL.)~* Patient and/or physician assessment or unchanged or worsened heart failure status at the time of recommended replacement time (RRT) for previous CRT device.~* Sinus Rhythm at the time of enrollment~Exclusion Criteria:~* Moderate to severe Aortic Stenosis~* Moderate to severe Mitral Regurgitation~* Patient age \<18 years old~* AF burden \>15%~* Severe pulmonary disease requiring supplemental oxygen use~* ESRD~* System Modification at RRT Generator Changeout~* AdaptivCRT prior to enrollment~* Expected patient longevity \< 1 year~* Persistant or chronic atrial fibriliation~* Women who are pregnant or who plan to become pregnant during the clinical trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Adaptiv CRT (Type: OTHER): Adaptiv CRT algorithm in Medtronic FDA approved CRT devices to be programmed as ON at 6 month follow-up visit

Based on this trial design, predict the completion outcome and termination type (if applicable).